Detachment of Membrane Bound Virions by Competitive Ligand Binding Induced Receptor Depletion.

Multivalent receptor-mediated interactions between virions and a lipid membrane can be weakened using competitive nonpathogenic ligand binding. In particular, the subsequent binding of such ligands can induce detachment of bound virions, a phenomenon of crucial relevance for the development of new antiviral drugs. Focusing on the simian virus 40 (SV40) and recombinant cholera toxin B subunit (rCTB), and using (monosialotetrahexosyl)ganglioside (GM1) as their common receptor in a supported lipid bilayer (SLB), we present the first detailed investigation of this phenomenon by employing the quartz crystal microbalance with dissipation (QCM-D) and total internal reflection fluorescence (TIRF) microscopy assisted 2D single particle tracking (SPT) techniques. Analysis of the QCM-D-measured release kinetics made it possible to determine the binding strength of a single SV40-GM1 pair. The release dynamics of SV40, monitored by SPT, revealed that a notable fraction of SV40 becomes mobile just before the release, allowing to estimate the distribution of SV40-bound GM1 receptors just prior to release.

[1]  Donald W. Lee,et al.  Image Restoration and Analysis of Influenza Virions Binding to Membrane Receptors Reveal Adhesion-Strengthening Kinetics , 2016, PloS one.

[2]  Vladimir P. Zhdanov,et al.  Quantification of Multivalent Interactions by Tracking Single Biological Nanoparticle Mobility on a Lipid Membrane. , 2016, Nano letters.

[3]  Guangdi Li,et al.  Approved Antiviral Drugs over the Past 50 Years , 2016, Clinical Microbiology Reviews.

[4]  Ying Guo,et al.  Influenza Viral Hemagglutinin Peptide Inhibits Influenza Viral Entry by Shielding the Host Receptor. , 2016, ACS infectious diseases.

[5]  A. Imberty,et al.  Glycomimetics versus multivalent glycoconjugates for the design of high affinity lectin ligands. , 2015, Chemical reviews.

[6]  Anne Imberty,et al.  Membrane deformation by neolectins with engineered glycolipid binding sites. , 2014, Angewandte Chemie.

[7]  Robert G. Parton,et al.  Galectin-3 drives glycosphingolipid-dependent biogenesis of clathrin-independent carriers , 2014, Nature Cell Biology.

[8]  Gustaf E. Rydell,et al.  Parvovirus B19 VLP recognizes globoside in supported lipid bilayers. , 2014, Virology.

[9]  Moritz Waldmann,et al.  A nanomolar multivalent ligand as entry inhibitor of the hemagglutinin of avian influenza. , 2014, Journal of the American Chemical Society.

[10]  Simon G. Patching,et al.  Surface plasmon resonance spectroscopy for characterisation of membrane protein-ligand interactions and its potential for drug discovery. , 2014, Biochimica et biophysica acta.

[11]  V. Zhdanov.  Physical aspects of the initial phase of endocytosis. , 2013, Physical review. E, Statistical, nonlinear, and soft matter physics.

[12]  Ivo F. Sbalzarini,et al.  Receptor Concentration and Diffusivity Control Multivalent Binding of Sv40 to Membrane Bilayers , 2013, PLoS Comput. Biol..

[13]  W. Lencer,et al.  A Single Native Ganglioside GM1-Binding Site Is Sufficient for Cholera Toxin To Bind to Cells and Complete the Intoxication Pathway , 2012, mBio.

[14]  V. Zhdanov,et al.  Interaction of single viruslike particles with vesicles containing glycosphingolipids. , 2011, Physical review letters.

[15]  S. Daniel,et al.  Measuring the partitioning kinetics of membrane biomolecules using patterned two-phase coexistant lipid bilayers. , 2011, Journal of the American Chemical Society.

[16]  Ari Helenius,et al.  Lipid-mediated endocytosis. , 2011, Cold Spring Harbor perspectives in biology.

[17]  L. Malinina,et al.  Dynamic modulation of the glycosphingolipid content in supported lipid bilayers by glycolipid transfer protein. , 2010, Biophysical journal.

[18]  M. Jiang,et al.  Glycosphingolipids as Receptors for Non-Enveloped Viruses , 2010, Viruses.

[19]  Petra Schwille,et al.  GM1 structure determines SV40-induced membrane invagination and infection , 2010, Nature Cell Biology.

[20]  Christian L. Müller,et al.  High-speed nanoscopic tracking of the position and orientation of a single virus , 2009, Nature Methods.

[21]  Gustaf E. Rydell,et al.  QCM-D studies of human norovirus VLPs binding to glycosphingolipids in supported lipid bilayers reveal strain-specific characteristics. , 2009, Glycobiology.

[22]  C. Kelly,et al.  Gold manno-glyconanoparticles: multivalent systems to block HIV-1 gp120 binding to the lectin DC-SIGN. , 2009, Chemistry.

[23]  N. Steinmetz,et al.  Solvation effects in the quartz crystal microbalance with dissipation monitoring response to biomolecular adsorption. A phenomenological approach. , 2008, Analytical chemistry.

[24]  Thilo Stehle,et al.  Structural basis of GM1 ganglioside recognition by simian virus 40 , 2008, Proceedings of the National Academy of Sciences.

[25]  Jun Zhang,et al.  Molecular Interactions of CCR5 with Major Classes of Small-Molecule Anti-HIV CCR5 Antagonists , 2008, Molecular Pharmacology.

[26]  Jun Zhang,et al.  Molecular Interactions of CCR 5 with Major Classes of Small-Molecule Anti-HIV CCR 5 Antagonists , 2008 .

[27]  Vahid Sandoghdar,et al.  Label-free optical detection and tracking of single virions bound to their receptors in supported membrane bilayers. , 2007, Nano letters.

[28]  Takashi Suzuki,et al.  Binding kinetics of influenza viruses to sialic acid-containing carbohydrates , 2007, Glycoconjugate Journal.

[29]  Jinjun Shi,et al.  GM1 clustering inhibits cholera toxin binding in supported phospholipid membranes. , 2007, Journal of the American Chemical Society.

[30]  S. Sonnino,et al.  Gangliosides as components of lipid membrane domains. , 2007, Glycobiology.

[31]  L. Johannes,et al.  Functionally different pools of Shiga toxin receptor, globotriaosyl ceramide, in HeLa cells , 2006, The FEBS journal.

[32]  Javier Rojo,et al.  Mannose hyperbranched dendritic polymers interact with clustered organization of DC‐SIGN and inhibit gp120 binding , 2006, FEBS letters.

[33]  David A. Price,et al.  Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity , 2005, Antimicrobial Agents and Chemotherapy.

[34]  A. Blom,et al.  Inhibition of Coxsackie B Virus Infection by Soluble Forms of Its Receptors: Binding Affinities, Altered Particle Formation, and Competition with Cellular Receptors , 2005, Journal of Virology.

[35]  Frederick A. Heberle,et al.  Crosslinking a lipid raft component triggers liquid ordered-liquid disordered phase separation in model plasma membranes. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[36]  S. Homans,et al.  Dissecting the cholera toxin-ganglioside GM1 interaction by isothermal titration calorimetry. , 2004, Journal of the American Chemical Society.

[37]  N. Bovin,et al.  Multimeric glycotherapeutics: New paradigm , 2004, Glycoconjugate Journal.

[38]  B. Deurs,et al.  Internalization of cholera toxin by different endocytic mechanisms. , 2001, Journal of cell science.

[39]  S. O. Smith,et al.  A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[40]  George M Whitesides,et al.  Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors. , 1998, Angewandte Chemie.

[41]  H. Handa,et al.  Purification and characterization of virus-like particles and pentamers produced by the expression of SV40 capsid proteins in insect cells. , 1996, Biochimica et biophysica acta.

[42]  G M Whitesides,et al.  Effective inhibitors of hemagglutination by influenza virus synthesized from polymers having active ester groups. Insight into mechanism of inhibition. , 1995, Journal of medicinal chemistry.

[43]  K. Karlsson,et al.  Microbial recognition of target-cell glycoconjugates. , 1995, Current opinion in structural biology.

[44]  M. Matrosovich.  Towards the development of antimicrobial drugs acting by inhibition of pathogen attachment to host cells: A need for polyvalency , 1989, FEBS letters.

[45]  E. Freire,et al.  Thermodynamics of intersubunit interactions in cholera toxin upon binding to the oligosaccharide portion of its cell surface receptor, ganglioside GM1. , 1989, Biochemistry.

[46]  H. Baumann,et al.  Turnover of plasma membrane glycoproteins and glycolipids of hepatoma tissue culture cells. , 1978, The Journal of biological chemistry.

[47]  J. Holmgren,et al.  Tissue Receptor for Cholera Exotoxin: Postulated Structure from Studies with GM1 Ganglioside and Related Glycolipids , 1973, Infection and immunity.